WANA (Aug 31) – The Research and Development Department of Royan Stem Cell Technology Company has announced the successful production and commercialization of a dry bio-dressing derived from the amniotic membrane (the innermost layer of the fetal membrane), designed to accelerate wound healing and reduce treatment complications.

 

Masoumeh Nouri, Head of Research and Development Department at Royan Stem Cell Technology, explained that the product is rich in extracellular matrix proteins, cytokines, and growth factors, all of which support faster tissue repair and regeneration. “Due to its low immunogenicity, the patient’s immune system does not reject the dressing, which allows wounds to heal more rapidly,” she said.

 

Collection and Processing of Amniotic Membrane

Nouri outlined the production process, noting that the amniotic membrane—normally discarded after childbirth—is collected under sterile conditions from healthy donors and processed in cleanroom facilities. Thanks to its high concentration of growth factors and nutrients, along with its suitable physical structure, the membrane can be effectively used as a wound dressing.

 

Storage Advantage: Room Temperature Stability

One of the key features of this new bio-dressing, Nouri added, is its ability to be stored at room temperature. This eliminates the need for specialized equipment such as refrigerators or freezers, making it more accessible for patients and healthcare providers. “This feature is particularly valuable for patients in remote areas and during transportation,” she noted.

 

Challenging Path to Commercialization

Nouri emphasized that achieving commercialization was not an easy process. “As the first product developed by Royan’s Placental Bioprocessing Unit, it required persistence and extensive effort. After completing the production dossier, we successfully obtained the necessary regulatory approvals and then expanded production and sales,” she explained.

 

According to her, Royan’s longstanding expertise in sourcing safe placental materials provided a strong competitive advantage, enabling the company to navigate regulatory and operational hurdles and bring the product to market.